Healthcare News – Read More Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call. The company’s CEO, Andrew Dudum, said in the earnings call that it was “currently developing a best-in-class peptides experience, including U.S. manufactured products, clinical-led guidance, and ongoing blood testing.” Dudum said in the call that the company…
Hims & Hers planning to sell compounded peptides
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
